Opyl Ltd. (AU:OPL) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Opyl Limited has issued 200,000 fully paid ordinary shares without investor disclosure requirements, adhering to compliance guidelines under the Corporations Act. As a forward-thinking AI company, Opyl is focused on revolutionizing clinical trials and medical research, aligning with its strategic growth objectives.
For further insights into AU:OPL stock, check out TipRanks’ Stock Analysis page.